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Although the adverse effect of overt
plumbism on physical growth has long been
recognized (1,2, the effect of low-level lead
exposure on physical growth was first
explored by Schwartz et al. using data from
the National Health and Nutrition
Examination Survey (NHANES) II of
1976-1980 (3). The NHANES II data for
2695 children 7 years old indicated that
blood lead level (range = 4-35 pg/dl) was a
statistically significant predictor ofchildren's
height, weight, and chest circumference,
with control for age, race, sex, and nutrition-
al covariates. However, the cross-sectional
nature of the NHANES II survey limited
causal inference regarding the relationship.
The results of subsequent studies have
been inconsistent. A retrospective study of
the growth of 54 children from birth to 48
months ofage suggested a negative correla-
tion between weight gain and higher blood
lead between 15 and 24 months ofage (4).
Two longitudinal studies did not find any
significant association between blood lead
and physical growth (5,6). In another longi-
tudinal study, covariate-adjusted heights at
15 and 33 months of age were negatively
associated with postnatal blood lead con-
centrations (7,8).
Considering that physical growth is a
time-integrated outcome, use ofbiomarkers
ofchronic exposure such as tooth lead and
bone lead might be more advantageous
than blood lead in investigating the associ-
ation. Blood lead reflects relatively recent
exposure over a few months, and the bio-
logical half-life oflead in children was sev-
eral times shorter than that for adults
(9,10). Indeed, with control for other vari-
ables, including the child's medical history,
dietary history, behavior, tobacco smoking
ofparents, and sociodemographic factors, a
study of Danish children showed an
inverse association between tooth lead and
height (11).
Lead concentrates in mineralized tissue
such as bone and teeth. The concentration
of lead in the circumpulpal dentin of
deciduous teeth has been a useful biomark-
er ofcumulative lead exposure in studies of
the chronic toxicity of lead (12). It pro-
vides more valid information than does
tooth enamel on systemic absorption of
environmental lead into the body over sev-
eral years prior to shedding (13-16).
Bone accumulates lead throughout life,
eventually serving as the repository for
95% of an individual's lead burden (17).
Because of the long half-life of lead in
bone, bone lead provides an index of
cumulative exposure over decades. Direct
measurement of lead in bone by means of
an in vivo X-ray fluorescence (XRF) tech-
nique has been developed as a promising
biomarker during the last decade (18,19).
On the basis of the electron orbit where it
provokes the emission of fluorescent pho-
tons from lead atoms, the XRF technique is
classified into L-line XRF (L-XRF) and K-
lineXRF (K-XRF).
The K-XRF technique is relatively sta-
ble and reliable. Its accuracy is not affected
by overlying skin thickness or movement,
and it permits measurement oflead levels in
bone cortex and marrow tissues deeper than
L-XRF (20,21). It is noninvasive, involves
low-level radiation dose (less than 2.5% of
the effective dose ofa chest X-ray examina-
tion in adults), and takes 15-30 min to
measure one bone site (longer time renders
better precision) (20,22).
To our knowledge, no studies examin-
ing the effect of chronic lead exposure on
body mass index (weight in kilograms
divided by the square of the height in
meters; BMI) have been previously report-
ed, although BMI, as an index of obesity,
has long been shown to be an important
risk factor for hypertension, diabetes, and
coronary heart disease (23,24). We investi-
gated the effect ofchronic lead exposure on
BMI as well as on weight and height in a
cohort that was examined at a 13-year inter-
val. We explored the cross-sectional rela-
tionship between dentin lead level and
physical growth in each examination ofthe
cohort, then assessed the longitudinal rela-
tionship between dentin lead level in child-
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hood and physical growth from childhood
through early adulthood. The study proto-
col was approved by the institutional
review boards of Children's Hospital
(Boston) and Brigham and Women's
Hospital, and informed consent was
obtained from all participants in the study.
Methods
Subjects. The initial sample was chosen
from a population of3329 first and second
graders in Chelsea and Somerville,
Massachusetts, between 1975 and 1978.
From this group, 270 English-speaking
children with initial dentin lead levels >24
ppm (upper 10th percentile) or <8.7 ppm
(lower 10th percentile) were recruited for a
study of neurobehavioral effects of lead.
Methods used to define eligible subjects are
described in detail elsewhere (25).
In 1988, 132 members (mean age, 18.4
years) ofthis cohort were recruited to par-
ticipate in a follow-up evaluation of their
neuropsychological performance. Of these,
79 subjects (60% of the base population)
participated in the additional follow-up in
1989 and 1990. Among thosewho did not,
5 (3.8%) refused, 34 (25.8%) could not be
located, 8 (6.0%) agreed to participate con-
tingent on a return visit to Boston during
the data collection period, 5 (3.8%) agreed
to participate but repeatedly failed to keep
appointments, and 1 withdrew consent
during the study.
To control for confounding by race, we
restricted the study to white subjects (N =
251 as of 1975-1978). Growth velocity has
been known to significantly increase after
calcium disodium ethylenediamine
tetraacetic acid (EDTA) chelation therapy
in lead-poisoned children aged 2-5 years
(26). Subjects with high dentin lead levels
were more likely to have undergone chela-
tion therapy in childhood than those with
low levels. Following chelation, subjects
might have lower internal doses oflead than
expected on the basis of their dentin lead
levels. Six subjects had a history of chela-
tion. To eliminate potential confounding
by chelation therapy, the principal analyses
were restricted to nonchelated subjects.
However, results from analyses including
the chelated subjects are also presented.
Physicalgrowth. Subjects' weight and
height were measured (in light clothes and
barefoot) to the nearest quarter pound and
quarter inch, respectively, with use of a
Health 0 Meter (Continental Scale Corp.,
Bridgeview, Illinois) at the initial interview
in 1975-1978 and during the examination
in 1989-1990.
Tooth lead measurement. Shed decidu-
ous teeth donated by subjects were cleansed
ultrasonically, and those with fillings were
discarded from consideration. The speci-
mens were then mounted in lead-free wax
on the cutting stage ofa Buehler low-speed
saw (Buehler Ltd., Lake Bluff, Illinois). A 1-
mm slice was taken from the central sagittal
plane of each tooth at a single pass. The
central slice was then placed on an anvil
and split with a small chisel along a line
from the pulp canal to the dentin-enamel
junction. The larger portions of the slices,
along with the residual adjacent segments,
were filed in numbered pill boxes for later
confirmatory analysis. The smaller portion,
composed primarily of dentin, was then
analyzed for lead by means ofanodic strip-
ping voltammetry, as described elsewhere
(24. Ifthree dentin lead values were avail-
able, two concordant values were required;
if four values were available, three concor-
dant values were required. We used the
mean ofall available dentin lead values for a
child as the exposure index.
Bone lead measurement. We measured
bone lead in the tibia and patella of each
patient using our prototype K-XRF instru-
ment (ABIOMED, Inc., Danvers, MA).
The physical principles, technical specifica-
tions, and validity of K-XRF instruments
are described in detail elsewhere (28-30).
In short, this instrument uses a 109Cd y-ray
source to provoke the emission of fluores-
cent photons from target tissue that are
detected, counted, and arrayed on a spec-
trum. The net lead signal is determined
after subtraction of background counts by
means of a linear least-squares algorithm.
The lead fluorescence signal is then nor-
malized to the elastic or coherently scat-
tered X-ray signal, which arises predomi-
nantly from the calcium and phosphorus
present in bone mineral. The unit ofmea-
surement is microgram oflead per gram of
bone mineral.
Because the instrument provides a con-
tinuous, unbiased point estimate that oscil-
lates around the true bone lead value, nega-
tive point estimates are sometimes pro-
duced when the true bone lead value is
close to zero. The instrument also provides
an estimate of uncertainty associated with
each measurement, which is derived from a
goodness of fit calculation of the spectrum
curves and is equivalent to a single standard
deviation. Although a minimum detectable
limit calculation oftwice this value has been
proposed for interpreting a bone lead esti-
mate for an individual (31), use ofall point
estimates makes better use ofthe data for a
population in epidemiologic studies
(32,33). Recently, we have specifically
addressed the methodological issues of
using negative values and values below the
conceptual limit of detection in epidemio-
logic studies (33). Our experiment indicat-
ed that retaining all values ofbone lead con-
centration provides less bias and greater effi-
ciency in comparing the mean or median
levels ofbone lead ofdifferent populations.
Measurements were taken at the mid-
shaft ofthe left tibia and at the left patella
after each region had been washed with a
50% solution of isopropyl alcohol. The K-
XRF beam collimator was seated perpendic-
ular to the bone surface for the tibia and at
300 in the lateral direction for the patella.
Covariates. Information on potential
confounding variables and effect modifiers
was obtained from data collected by ques-
tionnaire and examination in 1975-1978.
Age, sex, race, birth weight, mother's
socioeconomic status (dichotomized by
Hollingshead class I-IlI versus IV-V),
medical history of chelation therapy for
lead poisoning as of 1975-1978, and age at
the time of K-XRF measurement in
1989-1990 were selected apriori as poten-
tial covariates.
Statistical analysis. The main purpose
ofthe analysis was to relate physical growth
(dependent variables) to lead biomarkers
(independent variables) with control for
potential covariates. Before the main analy-
sis, extreme outliers in values of height,
weight, and BMI were detected by the gen-
eralized extreme studentized deviate (ESD)
many-outlier procedure, with a Bonferroni-
corrected level (34). Lowess smoothing
plots between covariate-adjusted dependent
variables and covariate-adjusted indepen-
dent variables were used to evaluate the
form ofthe dose-response relationship and
to suggest appropriate transformations of
variables (35).
Three sets of multiple linear regression
models were fitted (Fig. 1). First, to deter-
mine whether dentin lead level was cross-
sectionally associated with physical growth
in childhood (1975-1978), regressions of
dentin lead on each physical outcome were
carried out, with control for age, sex, birth
weight, and mother's socioeconomic status
(model 1). Second, to determine whether
the dentin lead level was prospectively asso-
ciated with changes in physical growth
between 7 and 20 years of age, regressions
of dentin lead on each physical outcome
were carried out, with control for age
increase, age as of 1975-1978, sex, moth-
er's socioeconomic status, and physical
growth as of 1975-1978 (model 2). Finally,
to determine whether bone lead levels
around the age of 20 years were retrospec-
tively associated with changes in physical
growth between 7 and 20 years of age,
regressions of bone lead levels (i.e., tibia
lead levels, patella lead levels, or mean bone
lead levels) on each physical outcome were
carried out, with coiAtrol for age increase,
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Figure 1. Longitudinal structure of the data and the
statistical models in the study of the effect of lead
exposure on physical growth. The dependent vari-
able of model 1 is physical parameter [weight,
height, or body mass index (BMI)J as of 1975-78.
Independent variables of model 1 are log10 dentin
lead level, age, sex, birth weight, and mother's
socioeconomic status as of 1975-78. For models 2
and 3,the dependentvariable is physical parameter
(weight, height, or BMI) change between 1975-78
and 1989-90.The independentvariable ofinterestis
log1o dentin lead level as of 1975-78for model 2 and
bone lead (tibia, patella, or mean bone lead) level
for model 3. Other independent variables adjusted
in models 2 and 3 are age as of 1975-78, age
increase between 1975-78 and 1989-90, sex, moth-
er's socioeconomic status as of 1975-78, and physi-
cal parameter (weight, height, or BMI, respectively)
age as of 1975-1978, sex, mother's socioe-
conomic status, and physical growth as of
1975-1978 (model 3-1 for tibia lead levels,
model 3-2 for patella lead levels, and model
3-3 for mean bone lead levels).
Results
A total of237 white subjects without a his-
tory ofchelation had complete information
for fitting model 1. An extreme outlier at
level <0.0002 (0.05/237) for BMI as of
1975-1978 was detected by the ESD pro-
cedure. This extremely obese child (weight
49.2 kg, height 1.27 m, and BMI 30.5
kg/M2 at the age of7.1 years) was excluded
from subsequent analyses. The remaining
236 subjects used in fitting model 1 did
not significantly differ from the remaining
nonchelated subjects in dentin lead,
weight, height, BMI, sex, birth weight, or
mother's socioeconomic status (Table 1).
Ofthe 79 participants in the last exami-
nation, 60 nonchelated white subjects had
complete information for fitting model 2,
which requires physical parameter variables
measured at both the 1975-1978 and the
1989-1990 examinations. The ESD proce-
dure detected two extreme outliers at level
<0.0008 (0.05/61) for BMI change between
1975-1978 and 1989-1990. One outlier,
with a BMI increase of23.2 kg/m2, had a
weight of 102.2 kg, a height of 1.60 m, and
a BMI of 39.9 kg/m2 at the age of 19.8
years. The other outlier, with a BMI
increase of 20.7 kg/m2, had a weight of
112.1 kg, a height of 1.68 m, and a BMI of
39.9 kg/M2 at the age of21.2years.
The 58 study subjects used in fitting
model 2 did not significantly differ from the
remaining nonchelated subjects in dentin
lead, physical growth as of 1975-1978, sex,
and birth weight. However, mother's socioe-
conomic status as of 1975-1978 for these
subjects was higher (p<0.0I by Fisher's exact
test). Out of these 58, 4 subjects did not
undergo bone lead measurements, resulting
in 54 subjects for model 3. They did not
significantly differ from the remaining
nonchelated subjects in dentin lead, physical
growth as of 1975-1978, sex, or birth
weight, but mother's socioeconomic status
did differ.
At the time ofthe 1975-1978 examina-
tion, weight, height, and BMI averaged
26.1 kg (SD = 5.1, range = 17.5-45.4), 1.26
m (SD = 0.06, range = 1.09-1.49), and
16.3 kg/M2 (SD = 2.3, range = 10.1-25.7),
respectively. Dentin lead levels averaged
14.9 (SD = 11.5, range = 2.8-66.3). At the
time of the 1989-1990 examination,
weight, height, and BMI averaged 69.7 kg
(SD = 15.5, range= (49.9-116.7), 1.71 m
(SD = 0.10, range = 1.55-1.91), and 23.65
kg/M2 (SD = 3.54, range = 18.09-33.03),
Table 1. Characteristics ofsubjects included in and excluded from analyses oflead and physical growth8
Model 1: subjects in 1975-78 study(N= 270) Model 2: nonchelated subjects,
Nonchelated, Chelated, 1989-90 study (N=76)
Characteristic Analyzed (N=236) excluded (N= 28)b excluded (N=6) Analyzed (N= 58) Excluded (N= 18)b
Age, 1975-78 (years) 7.4±0.6(5.9-9.0) 7.4_0.6(6.5-9) 7.3±0.9(6.1-8.9) 7.4±0.5(6.1-8.8) 7.4_0.7(6.5-8.42)
Sex(%female) 47 54 100 53 50
Birthweight(kg) 3.3±0.5(1.0-4.7) 3.3±0.6(2.0-4.6) 3.2±0.5(2.7-3.8) 3.4±0.5(2.2-4.4) 3.2±0.7(1.0-4.3)
Motherssocioeconomic status(% high) 11 8 0 10 24
Weight, 1975-78 (kg) 26.1±5.1 (17.5-45.4) 27.0±6.0(19.3-49.1) 20.5±2.1 (18.5-23.0) 26.3±5.3(17.5-43.1) 26.4±3.7(22.5-34.2)
Height, 1975-78(m) 1.26±0.06(1.09-1.49) 1.26±0.08(1.02-1.44) 1.19±0.04(1.14-1.25) 1.27±0.06(1.13-1.42) 1.28±0.07(1.19-1.44)
BMI, 1975-78(kg/M2) 16.3±2.3(10.1-25.7) 16.9±3.7(13.1-30.5) 14.4±1.0(13.0-15.3) 16.22.1 (13.3-21.8) 16.2±1.4(14.1-19.2)
Dentin lead asof1975-78(ppm) 14.9±11.5(2.8-66.3) 17.0±15.9(2.6-51.4) 35.9±15.8(18.9-61.2) 12.9±9.8(2.9-51.8) 13.6±11.5(4.6-50.4)
Log1odentin lead, 1975-78(ppm) 1.06±0.32(0.44-1.82) 1.06±0.38(0.41-1.71) 1.52±0.19(1.28-1.79) 1.00±0.31 (0.46-1.71) 1.03±0.29(0.66-1.70)
Age, 1989-90(years) NA NA NA 20.5±0.7(18.7-21.8) 20.3±1.0(18.8-21.7)
Weight, 1989-90(kg) NA NA NA 69.7±15.5(49.9-116.7) 75.7±16.3(59.0-112.1)
Height, 1989-90(m) NA NA NA 1.71±0.10(1.55-1.91) 1.28±0.07(1.19-1.44)
BMI, 1989-90(kg/M2) NA NA NA 23.6±3.54(18.09-33.03) 26.2±6.1 (20.4-39.9)
Weightchange from 1975-78 to 1989-90 (kg) NA NA NA 43.5±13.1 (23.8-80.5) 49.7±15.7(28.8-79.2)
Heightchangefrom 1975-78to 1989-90(m) NA NA NA 0.44±0.09(0.18-0.58) 0.42±0.08(0.30-0.60)
BMI changefrom 1975-78to 1989-90(kg/m2) NA NA NA 7.49±2.67(2.83-15.87) 10.44±5.55(4.90-23.15)
Tibia lead, 1989-90(pg/g)b NA NA NA 1.2+4.4(-7-13) 2.1±6.3(-9-19)
Patella lead, 1989-90(pg/g) NA NA NA 5.08.1 (-10-23) 5.4±9.9(-13-25)
Mean bone lead, 1989-90(pg/g) NA NA NA 3.14.7(-5.5-14) 3.9±4.8(-4-12.5)
Abbreviations: NA, notapplicable; BMI, body mass index.
8Means ± SD and ranges(in parentheses) presented where appropriate.
bSubjects excluded from analysis arethose with incomplete information, andthose of nonwhite race.
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respectively. Tibia and patella lead estimates
averaged 1.2 pg/g (SD =4.4, range = -7-13),
and 5.0 pg/g (SD = 8.1, range = -10-23),
respectively.
In exploratory data analyses, the lowess
smoothing cu1 res of covariate-adjusted
outcome variables and covariate-adjusted
predictor variables were curvilinear and
slightly upwardly convex. Lowess smooth-
ing after logarithmic transformation of
dentin lead levels provided a more linear
fit. For the sake of interpretability of the
scale, we used log1o dentin lead level in lin-
ear regression analyses.
With control for age as of 1975-1978,
sex, birth weight, and mother's socioeco-
nomic status, loglo dentin lead in
nonchelated, nonoutlying subjects was sig-
nificantly associated with BMI (N= 236, f
= 1.02, 95% CI, 0.12-1.93, p = 0.03;
Table 2), but not with weight or with
height. The inclusion of chelated subjects
slightly reduced the regression coefficient
for BMI oflog10 dentin lead (N= 240, 13 =
0.88, 95% CI, -0.01-1.76, p = 0.05).
Additional inclusion of an extreme outlier
obscured the association between BMI and
log1o dentin lead (N= 241, f = 0.65, 95%
CI, 0.31-1.60, p = 0.19). When the same
regression models were fitted to a subgroup
who participated in the 1989-1990 exami-
nation and had complete information for
model 2, the confidence bounds were
slightly widened, which might result from
reduced sample size (N= 58, f3 = 1.82,
95% CI, -0.06-3.69, p = 0.06).
With control for BMI as of1975-1978,
age increase, age as of 1975-1978, sex, and
mother's socioeconomic status, log1o dentin
lead was significantly associated with BMI
change between 1975-1978 and 1989-1990
among nonchelated, nonoutlying subjects
(f3 = 2.65, 95% CI, 0.33-4.97,p= 0.03; Table
2). The inclusion of a chelated subject did
not appreciably change the regression coef-
ficient for BMI change oflog1o dentin lead
(1 = 2.50, 95% CI, 0.27-4.74, p = 0.03).
However, inclusion of the two outliers
obscured the association (f = 2.48, 95% CI,
0.79-5.75, p = 0.13). There were no signifi-
cant associations between log1o dentin lead
and weight, or between log1o dentin lead
and height.
No significant association was observed
between bone lead as of1989-1990 and any
of the changes in physical growth between
1975-1978 and 1989-1990, with control
for physical growth as of 1975-1978, age
increase, age as of 1975-1978, sex, and
mother's socioeconomic status. The results
were similar when chelated subjects and/or
outliers were included.
Discussion
We observed a weak but significantly posi-
tive association between childhood dentin
lead level and BMI in both cross-sectional
and longitudinal analyses. A 10-fold
increase in dentin lead level was associated
with an increase of 1.02 kg/m2 in BMI at
the age of 7 years. A 10-fold increase in
dentin lead level was also associated with
an increase in BMI change of 2.65 kg/m2
from age 7 to age 20.
The point estimates of the regression
coefficient for weight and for change in
weight were positive; those for height and
for change in height were negative, but
their interval estimates all included zero.
Because increased BMI results from
increased weight and/or decreased height,
it may have served as a more sensitive indi-
cator for the association between physical
growth and chronic lead exposure in our
study. Bone lead levels at the age of 20
years were not significantly associated with
Table 2. Partial regression coefficient of log10 dentin lead (ppm) in multiple linear regression of physical
growth in study ofthe relationship between lead exposure and physical growth8
Partial regression coefficient dependentvariables
Model (N) Weight(kg) Height(m) BMI (kg/M2)
1 (236) 1.340(0.991)b -0.009 (0.011) 1.023*(0.458)
2(58) 7.118 (4.176) -0.028 (0.025) 2.650* (1.156)
3-1 (54) -0.038 (0.327) -0.003 (0.002) 0.077 (0.088)
3-2(54) -0.187 (0.159) -0.001 (0.001) -0.042(0.043)
3-3(54) -0.314(0.286) -0.003(0.002) -0.037(0.078)
BMI, body mass index.
8Dependent variable of model 1 is weight, height, or BMI as of 1975-78. Independentvariables of model 1
are log10 dentin lead level, age, sex, birth weight, and mother's socioeconomic status as of 1975-78. For
models 2, 3-1, 3-2 and 3-3, dependent variable is change in weight, in height, or in BMI between 1975-78
and 1989-90. Independent variable of interest is log10 dentin lead level as of 1975-78 for model 2;tibia lead
level for model 3-1, patella lead level for model 3-2, and mean bone lead level as of 1989-90 for model
3-3. Other independent variables adjusted in models 2 and 3 are age as of 1975-78, age increase between
1975-78 and 1989-90, sex, mother's socioeconomic status as of 1975-78, and physical parameter (weight,
height, or BMI, respectively) as of 1975-78.
Standard errors in parentheses.
*p<0.05.
anyphysical growth changes between 7 and
20 years ofage.
Because dentin lead level reflects chron-
ic exposure to lead during the several years
prior to the shedding ofteeth, our findings
suggest that children exposed to lead in
early childhood experience greater BMI
gain during the period between 7 and 20
years of age than those less exposed. It is
possible that obese children ingested more
environmental lead from tap water, canned
foods, dusts, and paint chips during early
childhood. This reverse causality can
explain the cross-sectional association, but
hardly the longitudinal association. In our
longitudinal model, the exposure (the accu-
mulation of lead in the tooth) obviously
preceded the effect (the increase in BMI),
thereby supporting the attribution of a
causal role to lead.
Blood lead level was inversely associated
with both height and weight in NHANES
II data (3). An association of blood lead
with BMI was not examined, and the index
of exposure was blood lead, not dentin
lead, in the NHANES II. Thus, any com-
parison between this study and the
NHANES II studyshould be made careful-
ly. Nevertheless, it may be interesting to
examine whether there is also a significant
association between blood lead and BMI in
the NHANES II data.
On the basis ofcoefficients ofvariation
for weight (approximately 20%) and for
height (approximately 5%) in our data, we
estimated that the cross-sectional analysis
ofthe 1975-1978 data (N= 236) had 80%
power to detect the 7% difference in mean
ofweight and the 1.8% difference in mean
of height. Smaller effects would not be
detectable with 80% power.
Reduced pituitary responsiveness to
hypothalamic stimuli in terms of growth
hormone releasing factor or thyrotropin-
releasing hormone has been postulated as a
pathophysiologic mechanism for lead's
effect on physical growth. A recent neu-
roendocrine study showed that peak human
growth hormone and insulinlike growth
factor I responses to the L-dopa insulin test
were low in lead-poisoned children (26).
The authors concluded that lead-induced
reduction in stature may be due to dimin-
ished human growth hormone secretion,
which in turn results in reduced insulinlike
growth factor I secretion, or that lead may
directly inhibit insulinlike growth factor I
formation. Blunted response of thyroid-
stimulating hormone and growth hormone
to stimulatory challenge have been observed
in lead-poisoned children (36) as well as in
rats exposed to low-level lead (3). It is pos-
sible that our findings reflect similar
endocrine effects oflow-level lead exposure.
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The positive findings of this study may
have resulted by chance. As we conducted
multiple statistical tests using the same data
set, the probability ofa type I error may be
larger than the nominal level of0.05. Thus,
further study with a larger sample size is
encouraged to corroborate our findings.
A possible source of bias is our limited
success in locating and enrolling members
of the cohort for follow-up because of the
increased migration from home that occurs
around age 20. However, the characteristics
of the population, including dentin lead
levels, did not differ significantly between
those who participated in this follow-up
and those who did not. As physical growth
and covariates were measured blindly with
respect to the status ofdentin and bone lead
levels, observation bias is not likely.
We eliminated potential confounding
effects of race and chelation by restricting
the main analysis to white, nonchelated
subjects. However, such potential con-
founding variables as food intake and
parental body size were not controlled for
in our study because this information was
not available. We intended to reduce con-
founding effects of those variables by
adjusting for mother's socioeconomic sta-
tus. Still, it is possible that genetic (38,3591
and nongenetic risk factors (23) for
increased BMI might result in increased
dentin lead levels through unknown mech-
anism. Further studies more thoroughly
controlling for those potential confounders
are awaited.
BMI is a major risk factor for elevated
blood pressure (23,24). It has been noted
that blood pressure was positively associat-
ed with blood lead levels before and after
control for age, BMI, and other related fac-
tors (40-45). However, the association
between blood lead and blood pressure is
not conclusive yet (45), because it is very
weak (1 to 2 mm Hg for every doubling in
blood lead levels in middle-aged men) and
influenced by the inclusion ofcovariates in
the statistical model such as alcohol con-
sumption and cigarette smoking (41).
Our finding that childhood lead expo-
sure may predict increased BMI that per-
sists into adulthood is suggestive ofan indi-
rect path to elevated blood pressure related
to chronic lead exposure. If our finding is
replicable and robust, the ramifications are
significant. The previously described associ-
ation between low-level lead exposure and
elevated blood pressure may be stronger
than currently assumed, ifthe effect oflead
on obesity is also taken into account.
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